CHAMPIONS ONCOLOGY, INC.
For the period ended Aug 27, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 27, 2026 · Filed Aug 28, 2026
Contents
Certain Relationships and Related Transactions
During the years ended April 30, 2026 and 2025, we engaged in the following transactions with our directors, executive officers, nominees for director, immediate family members of our directors, executive officers or nominees, and beneficial owners of 5% or more of our common stock:
Dr. Sidransky, who is one of our directors, and who beneficially owned approximately 6.0% of our common stock as of the Record Date, received $0 and $12,000 in consulting fees from us during the fiscal years ended April 30, 2026 and 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.